Cocaine and sleep: Early abstinence

TheScientificWorldJournal

Volumn 7, Issue SUPPL. 2, 2007, Pages 223-230

  Morgan, Peter T ^a   Malison, Robert T ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abstinence; Cocaine; GABA; Insomnia; Sleep; Treatment

Indexed keywords

COCAINE; GABOXADOL; MODAFINIL; TIAGABINE; TOPIRAMATE; VIGABATRIN;

COCAINE DEPENDENCE; DRUG USE; DRUG WITHDRAWAL; HUMAN; POLYSOMNOGRAPHY; REM SLEEP; SELF REPORT; SEX DIFFERENCE; SHORT SURVEY; SLEEP; SLEEP PARAMETERS;

COCAINE; COCAINE-RELATED DISORDERS; HUMANS; POLYSOMNOGRAPHY; SLEEP; SLEEP DEPRIVATION; TIME FACTORS;

EID: 37349128976     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2007.209     Document Type: Short Survey

References (42)

1. Breslau, N. et al. (1996) Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol. Psychiatry 39(6), 411-418.
2. Fava, M. et al. (2006) Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol. Psychiatry 59(11), 1052-1060.
3. Le Bon, O. (2005) Contribution of sleep research to the development of new antidepressants. Dialogues Clin. Neurosci. 7(4), 305-313.
4. Monnelly, E.P. et al. (2004) Quetiapine for treatment of alcohol dependence. J. Clin. Psychopharmacol. 24(5), 532-535.
5. Brower, K.J., Aldrich, M.S., and Hall, J.M. (1998) Polysomnographic and subjective sleep predictors of alcoholic relapse. Alcohol Clin. Exp. Res. 22(8), 1864-1871.
6. Brower, K.J. (2003) Insomnia, alcoholism and relapse. Sleep Med. Rev. 7(6), 523-539.
7. Landolt, H.P. and Gillin, J.C. (2001) Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management. CNS Drugs 15(5), 413-425.
8. Morgan, P.T. et al. (2007) Cocaine, Sleep Architecture, and Visual Learning, in revision.
9. Morgan, P.T. et al. (2006) Sleep, sleep-dependent procedural learning and vigilance in chronic cocaine users: evidence for occult insomnia. Drug Alcohol Depend. 82(3), 238-249.
10. Pace-Schott, E.F. et al. (2005) Sleep quality deteriorates over a binge-abstinence cycle in chronic smoked cocaine users. Psychopharmacology (Berl.) 179(4), 873-883.
11. Pace-Schott, E.F. et al. (2005) Cognitive performance by humans during a smoked cocaine binge-abstinence cycle. Am. J. Drug Alcohol Abuse 31, 571-591.
12. Kowatch, R.A. et al. (1992) Electroencephalographic sleep and mood during cocaine withdrawal. J. Addict. Dis. 11(4), 21-45.
13. Johanson, C.E. et al. (1999) The effects of cocaine on mood and sleep in cocaine-dependent males. Exp. Clin. Psychopharmacol. 7(4), 338-346.
14. Thompson, P.M. et al. (1995) Polygraphic sleep measures differentiate alcoholics and stimulant abusers during short-term abstinence. Biol. Psychiatry 38(12), 831-836.
15. Gillin, J.C. et al. (1994) The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report. Biol. Psychiatry 35(11), 843-849.
16. Watson, R. et al. (1992) Cocaine use and withdrawal: the effect on sleep and mood. Am. J. Drug Alcohol Abuse 18(1), 21-28.
17. Weddington, W.W. et al. (1990) Changes in mood, craving, and sleep during short-term abstinence reported by male cocaine addicts. A controlled, residential study. Arch. Gen. Psychiatry 47(9), 861-868.
18. Coffey, S.F. et al. (2000) Acute and protracted cocaine abstinence in an outpatient population: a prospective study of mood, sleep and withdrawal symptoms. Drug Alcohol Depend. 59(3), 277-286.
19. Durmer, J.S. and Dinges, D.F. (2005) Neurocognitive consequences of sleep deprivation. Semin. Neurol. 25(1), 117-129.
20. Jewett, M.E. et al. (1999) Dose-response relationship between sleep duration and human psychomotor vigilance and subjective alertness. Sleep 22(2), 171-179.
21. Van Dongen, H.P. et al. (2003) The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 26(2), 117-126.
22. Aharonovich, E., Nunes, E., and Hasin, D. (2003) Cognitive impairment, retention and abstinence among cocaine abusers in cognitive-behavioral treatment. Drug Alcohol Depend. 71(2), 207-211.
23. Teichner, G., Horner, M.D., and Harvey, R.T. (2001) Neuropsychological predictors of the attainment of treatment objectives in substance abuse patients. Int. J. Neurosci. 106(3-4), 253-263.
24. Teichner, G. et al. (2002) Substance abuse treatment outcomes for cognitively impaired and intact outpatients. Addict. Behav. 27(5), 751-763.
25. Morgan, P.T. et al. (2007) Gender Differences in Sleep and Sleep-Dependent Learning in Abstinent Cocaine Users. Presentation. College on Problems of Drug Dependence (CPDD) Annual Meeting, Quebec City, June 17-21.
26. Centonze, D. et al. (2002) Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors. Neuropsychopharmacology 26(2), 164-175.
27. Doherty, M. and Gratton, A. (2007) Differential involvement of ventral tegmental GABA(A) and GABA(B) receptors in the regulation of the nucleus accumbens dopamine response to stress. Brain Res. 1150, 62-68.
28. Barrett, A.C. et al. (2005) Effect of GABA agonists and GABA-A receptor modulators on cocaine- and food-maintained responding and cocaine discrimination in rats. J. Pharmacol. Exp. Ther. 315(2), 858-871.
29. Haney, M., Hart, C.L., and Foltin, R.W. (2006) Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology 31(8), 1814-1821.
30. Roberts, D.C. (2005) Preclinical evidence for GABAB agonists as a pharmacotherapy for cocaine addiction. Physiol. Behav. 86(1-2), 18-20.
31. Weerts, E.M., Froestl, W., and Griffiths, R.R. (2005) Effects of GABAergic modulators on food and cocaine self-administration in baboons. Drug Alcohol Depend. 80(3), 369-376.
32. Johnson, B.A. (2005) Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function. CNS Drugs 19(10), 873-896.
33. Gonzalez, G. et al. (2003) Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction 98(11), 1625-1632.
34. Gonzalez, G. et al. (2007) Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug Alcohol Depend. 87(1), 1-9.
35. Brodie, J.D., Figueroa, E., and Dewey, S.L. (2003) Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA. Synapse 50(3), 261-265.
36. Winhusen, T.M. et al. (2005) A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 100(Suppl 1), 68-77.
37. Walsh, J.K. et al. (2006) Tiagabine is associated with sustained attention during sleep restriction: evidence for the value of slow-wave sleep enhancement? Sleep 29(4), 433-443.
38. Kampman, K.M. et al. (2004) A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend. 75(3), 233-240.
39. Dackis, C.A. et al. (2005) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 30(1), 205-211.
40. Chapotot, F. et al. (2003) Distinctive effects of modafinil and d-amphetamine on the homeostatic and circadian modulation of the human waking EEG. Psychopharmacology (Berl.) 166(2), 127-138.
41. Winsky-Sommerer, R. et al. (2007) The EEG effects of THIP (Gaboxadol) on sleep and waking are mediated by the GABA(A)delta-subunit-containing receptors. Eur. J. Neurosci. 25(6), 1893-1899.
42. Orser, B.A. (2006) Extrasynaptic GABAA receptors are critical targets for sedative-hypnotic drugs. J. Clin. Sleep Med. 2(2), S12-18.